High Prevalence and Low Awareness of Albuminuria in the Community Setting in the KDSAP.
Kidney Disease Screening and Awareness Program (KDSAP)
albuminuria
awareness
chronic kidney disease (CKD)
community screening
proteinuria
Journal
Kidney international reports
ISSN: 2468-0249
Titre abrégé: Kidney Int Rep
Pays: United States
ID NLM: 101684752
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
received:
20
04
2019
revised:
26
11
2019
accepted:
16
12
2019
entrez:
14
4
2020
pubmed:
14
4
2020
medline:
14
4
2020
Statut:
epublish
Résumé
Albuminuria is a sign of kidney disease and associated with adverse outcomes. However, most individuals with albuminuria are unaware of it. The Kidney Disease Screening and Awareness Program (KDSAP) aims for early detection and raising awareness of albuminuria, targeting underserved populations in communities. This study will assess the prevalence and awareness of albuminuria and identify associated risk factors among KDSAP participants. KDSAP participants ≥18 years old without a history of dialysis or kidney transplant were included. Albuminuria was identified by dipstick urinalysis. Individuals with albuminuria who answered Among 2304 participants, 461 (20.0%) had albuminuria: 16.3% with trace or 1+ (low degree) and 3.7% with 2+ or more (high degree). Correlating factors of albuminuria included young age, male sex, African American descent, self-reported diabetes, hypertension, family history of kidney disease, and smoking. Overall albuminuria awareness was 15.8%, but awareness inversely correlated to younger age groups: 7.0% for ages 18-39 years, 13.5% for ages 40-59 years, and 24.0% for ages ≥60 years ( There was a high albuminuria prevalence among KDSAP participants, yet low awareness. KDSAP can potentially be a useful model for detecting albuminuria and raising awareness in communities.
Identifiants
pubmed: 32280843
doi: 10.1016/j.ekir.2019.12.011
pii: S2468-0249(19)31598-0
pmc: PMC7136433
doi:
Types de publication
Journal Article
Langues
eng
Pagination
475-484Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2020 International Society of Nephrology. Published by Elsevier Inc.
Références
Lancet. 2010 Jun 12;375(9731):2073-81
pubmed: 20483451
Intern Med. 2017;56(12):1475-1484
pubmed: 28626171
Lancet Diabetes Endocrinol. 2015 Jul;3(7):514-25
pubmed: 26028594
Am J Kidney Dis. 2015 Mar;65(3):412-24
pubmed: 25458663
Am J Med. 2012 Jul;125(7):661-9
pubmed: 22626510
Stroke. 2015 Aug;46(8):2075-80
pubmed: 26130097
Am J Kidney Dis. 2018 Nov;72(5):653-661
pubmed: 29784612
Clin Chem. 2013 Apr;59(4):675-83
pubmed: 23315482
Am J Prev Med. 2017 Sep;53(3):300-307
pubmed: 28410862
JAMA. 2010 Feb 3;303(5):423-9
pubmed: 20124537
Am J Kidney Dis. 2009 Feb;53(2):238-47
pubmed: 19166799
JAMA. 2007 Nov 7;298(17):2038-47
pubmed: 17986697
Clin J Am Soc Nephrol. 2018 Apr 6;13(4):551-559
pubmed: 29545381
Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S1-3
pubmed: 23507265
Stat Methods Med Res. 1996 Sep;5(3):215-38
pubmed: 8931194
Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S12-23
pubmed: 23507266
PLoS One. 2017 Feb 2;12(2):e0171106
pubmed: 28151999
Am J Kidney Dis. 2011 Jul;58(1):19-28
pubmed: 21411199
Clin J Am Soc Nephrol. 2016 Sep 7;11(9):1566-73
pubmed: 27340288
PLoS One. 2012;7(10):e47100
pubmed: 23056593
J Am Soc Nephrol. 2014 Sep;25(9):1909-15
pubmed: 24876120
J Nephrol. 2013 Sep-Oct;26(5):949-52
pubmed: 24052467
Arch Intern Med. 2008 Nov 10;168(20):2268-75
pubmed: 19001205
BMC Nephrol. 2014 Jul 10;15:112
pubmed: 25012542
Adv Chronic Kidney Dis. 2010 May;17(3):225-36
pubmed: 20439091